RVPH - Reviva Pharmaceuticals Holdings . - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

RVPH is currently covered by 3 analysts with an average price target of $14.3. This is a potential upside of $11.21 (362.78%) from yesterday's end of day stock price of $3.09.

Reviva Pharmaceuticals Holdings .'s activity chart (see below) currently has 1 price targets and 13 ratings on display. The stock rating distribution of RVPH is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for RVPH is $20, Lowest price target is $12, average price target is $14.3.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 22-Apr-2024. First documented stock forecast 26-Jul-2021.

Best performing analysts who are covering RVPH - Reviva Pharmaceuticals Holdings .:

Raghuram Selvaraju Jason Mccarthy Scott Henry

Currently out of the existing stock ratings of RVPH, 12 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

20

$16.91 (547.25%)

20

2 days ago

0/9 (0%)

$16.91 (547.25%)

Buy

12

$8.91 (288.35%)

12

5 months 25 days ago

0/2 (0%)

$6.51 (118.58%)

Buy

18

$14.91 (482.52%)

10

11 months 21 days ago

0/2 (0%)

$10.2 (130.77%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RVPH (Reviva Pharmaceuticals Holdings .) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on RVPH (Reviva Pharmaceuticals Holdings .) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on RVPH (Reviva Pharmaceuticals Holdings .) with a proven track record?

SCOTT HENRY

Which analyst has the most public recommendations on RVPH (Reviva Pharmaceuticals Holdings .)?

Raghuram Selvaraju has 3 price targets and 16 ratings on RVPH

Which analyst is the currently most bullish on RVPH (Reviva Pharmaceuticals Holdings .)?

Raghuram Selvaraju with highest potential upside - $16.91

Which analyst is the currently most reserved on RVPH (Reviva Pharmaceuticals Holdings .)?

Scott Henry with lowest potential downside - $8.91

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?